Table 2.
Site | ||||||||
---|---|---|---|---|---|---|---|---|
Eo | GCaF and Co | GCo | GCoA | GA | D | Total | ||
Age group | ||||||||
Under 45 | n | 10 | 23 | 3 | 12 | 1 | 2 | 51 |
% wag | 19.6 | 45.1 | 5.9 | 23.5 | 2.0 | 3.9 | 100 % | |
% ws | 8.6 | 14.8 | 9.4 | 18.5 | 1.9 | 33.3 | 11.9 % | |
% T | 2.3 | 5.4 | 0.7 | 2.8 | 0.2 | 0.5 | 11.9 % | |
46–55 | n | 13 | 15 | 8 | 6 | 12 | 1 | 55 |
% wag | 23.6 | 27.3 | 14.5 | 10.9 | 21.8 | 1.8 | 100 % | |
% ws | 11.2 | 9.7 | 25.0 | 9.2 | 22.6 | 16.7 | 12.9 % | |
% T | 3.0 | 3.5 | 1.9 | 1.4 | 2.8 | 0.2 | 12.9 % | |
56–65 | n | 51 | 43 | 8 | 3 | 18 | 1 | 124 |
% wag | 41.1 | 34.7 | 6.5 | 2.4 | 14.5 | 0.8 | 100 % | |
% ws | 44.0 | 27.7 | 25.0 | 4.6 | 34.0 | 16.7 | 29.0 % | |
% T | 11.9 | 10.1 | 1.9 | 0.7 | 4.2 | 0.2 | 29.0 % | |
66–75 | n | 32 | 39 | 12 | 27 | 10 | 1 | 121 |
% wag | 26.4 | 32.2 | 9.9 | 22.3 | 8.3 | 0.8 | 100 % | |
% ws | 27.6 | 25.2 | 37.5 | 41.5 | 18.9 | 16.7 | 28.3 % | |
% T | 7.5 | 9.1 | 2.8 | 6.3 | 2.3 | 0.2 | 28.3 % | |
75 + | n | 10 | 35 | 1 | 17 | 12 | 1 | 76 |
% wag | 13.2 | 46.1 | 1.3 | 22.4 | 15.8 | 1.3 | 100 % | |
% ws | 8.6 | 22.6 | 3.1 | 26.2 | 22.6 | 16.7 | 17.8 % | |
% T | 2.3 | 8.2 | 0.2 | 4.0 | 2.8 | 0.2 | 17.8 % | |
n | 116 | 155 | 32 | 65 | 53 | 6 | 427 | |
% wag | 27.2 | 36.3 | 7.5 | 15.2 | 12.4 | 1.4 | 100 % | |
% ws | 100 | 100 | 100 | 100 | 100 | 100 | 100 % | |
% T | 27.2 | 36.3 | 7.5 | 15.2 | 12.4 | 1.4 | 100 % |
wag with in age group, ws with in site, T total, n frequency, Eo esophageal, GCaF and Co Cardia and fundus or corpus or all of them, GCo corpus, GCoA corpus and antrum, GA antrum, D duodenum